The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, single-arm phase Ib/II study of immune combination therapy with elotuzumab and belantamab mafodotin in patients with relapsed refractory multiple myeloma.
 
Sabrina Browning
Research Funding - Janssen
 
Fangyong Li
No Relationships to Disclose
 
Terri L. Parker
No Relationships to Disclose
 
Noffar Bar
No Relationships to Disclose
 
Tara Anderson
No Relationships to Disclose
 
Erica Stevens
No Relationships to Disclose
 
Jennifer VanOudenhove
No Relationships to Disclose
 
Martin Matthews
No Relationships to Disclose
 
Elan Gorshein
Consulting or Advisory Role - Abbvie; Janssen
 
Ashita D. Talsania
No Relationships to Disclose
 
Kert D. Sabbath
No Relationships to Disclose
 
Stuart Seropian
Consulting or Advisory Role - Carrum Health
 
Stephanie Halene
Honoraria - FORMA Therapeutics
Research Funding - AstraZeneca; STORM Therapeutics
 
Natalia Neparidze
Research Funding - GlaxoSmithKline; Janssen